Rupesh Dash

5PUBLICATIONS
1CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2025
NEK9-mediated Wnt signalling repressor TLE3 rewires Docetaxel resistance in cancer cells by inducing pyroptosis.

Shamima Azma Ansari, Sibasish Mohanty, Pallavi Mohapatra

|Mar 25, 2021
RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway.

Omprakash Shriwas, Rakesh Arya, Sibasish Mohanty

|Jan 25, 2020
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.

Omprakash Shriwas, Manashi Priyadarshini, Sabindra K Samal

Pageof 1

Frequent Collaborators